L Wartofsky

Author PubWeight™ 100.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993 3.71
2 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003 3.24
3 Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves disease. Ann Intern Med 1994 2.57
4 Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993 2.23
5 Optimal use of blood tests for assessment of thyroid function. JAMA 1993 2.00
6 Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 2013 1.89
7 Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev 1982 1.81
8 Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab 1995 1.62
9 Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging. J Nucl Med 1990 1.41
10 Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990 1.39
11 In vitro dissolution of calcium carbonate preparations. Calcif Tissue Int 1991 1.38
12 Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2000 1.28
13 The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Invest 2003 1.17
14 Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid 1994 1.15
15 Failure of oral water loading and intravenous hypotonic saline to suppress plasma prolactin in man. J Clin Endocrinol Metab 1975 1.15
16 Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am 1996 1.13
17 Isolated thyrotropin deficiency with thyrotropin-releasing-hormone induced TSH secretion and thyroidal release. J Clin Endocrinol Metab 1976 1.09
18 Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology 2013 1.08
19 Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest 1970 1.08
20 Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report. Thyroid 1998 1.05
21 Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results. JAMA 1973 1.02
22 Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 1993 1.01
23 Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. Ann Intern Med 1988 0.99
24 Metastatic occult follicular thyroid carcinoma. JAMA 1976 0.99
25 Hyperthyroid heart disease. Clin Cardiol 2000 0.98
26 Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab 1980 0.97
27 Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 1996 0.96
28 Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg 2000 0.94
29 Hemiagenesis of the thyroid gland. Am J Med 1975 0.94
30 Measurement of serum T4 concentration by high performance liquid chromatography. J Clin Endocrinol Metab 1981 0.94
31 Alterations in magnesium and zinc metabolism in thyroid disease. Metabolism 1988 0.92
32 Abnormalities of liver function tests in tyrotoxicosis. Mil Med 1978 0.91
33 Ultrasound-guided fine-needle aspiration and thyroid disease. Otolaryngol Head Neck Surg 2000 0.91
34 Acromegaly. Treatment by transsphenoidal microsurgery. JAMA 1975 0.90
35 Measurement of 3,3',5'-Triiodothyroinine (reverse T3), 3,3'-L-diiodothyronine, T3 and T4 in human amniotic fluid and in cord and maternal serum. J Clin Endocrinol Metab 1976 0.88
36 Iodine effects on the thyroid gland: biochemical and clinical aspects. Rev Endocr Metab Disord 2000 0.88
37 The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Metabolism 1979 0.88
38 The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab 2001 0.87
39 Failure of propranolol to alter thyroid iodine release, thyroxine turnover, or the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. J Clin Endocrinol Metab 1975 0.87
40 Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1991 0.87
41 The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer. Thyroid 2006 0.87
42 Characterization by affinity cross-linking of a receptor for atrial natriuretic peptide in cultured human thyroid cells associated with reductions in both adenosine 3',5'-monophosphate production and thyroglobulin secretion. J Clin Endocrinol Metab 1990 0.86
43 Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 1999 0.86
44 T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate model. Crit Care Med 1983 0.86
45 The role of radioactive iodine in salivary gland dysfunction. Ear Nose Throat J 2000 0.86
46 Free T4, free T3, and reverse T3 in critically ill, thermally injured patients. J Trauma 1980 0.85
47 Studies on the nature of thyroidal suppression during acute falciparum malaria: integrity of pituitary response to TRH and alterations in serum T3 and reverse T3. J Clin Endocrinol Metab 1977 0.85
48 Antithyrotropin antibodies in the sera of Graves' disease patients. J Clin Endocrinol Metab 1985 0.85
49 Investigations into the etiology of elevated serum T3 levels in protein-malnourished rats. Metabolism 1982 0.85
50 Nature of suppressed TSH secretion during undernutrition: effect of fasting and refeeding on TSH responses to prolonged TRH infusions. Metabolism 1980 0.85
51 Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone. J Clin Endocrinol Metab 1979 0.85
52 Remission rates with antithyroid drug therapy: continuing influence of iodine intake? Ann Intern Med 1987 0.85
53 A radioimmunoassay for 3,3'-L-diiodothyronine (3,3'T2). J Clin Endocrinol Metab 1977 0.84
54 Reduction in hepatic triiodothyronine binding capacity induced by fasting. Endocrinology 1977 0.84
55 Serum triiodothyronine in undernourished rats: dependence on dietary composition rather than total calorie or protein intake. Endocrinology 1978 0.83
56 Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients. Thyroid 1999 0.83
57 Glucose modulation of alterations in serum iodothyronine concentrations induced by fasting. Metabolism 1979 0.82
58 Resin hemoperfusion: a method of removing circulating thyroid hormones. J Clin Endocrinol Metab 1976 0.82
59 Common thyroid disorders in the elderly. Postgrad Med 1992 0.82
60 Effect of acute increases in serum triiodothyronine on TSH and prolactin responses to TRH, and estimates of pituitary stores of TSH and prolactin in normal subjects and in patients with primary hypothyroidism. J Clin Endocrinol Metab 1976 0.82
61 Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor. J Endocrinol Invest 1992 0.82
62 Absence of retroviral sequences in Graves' disease. Lancet 1991 0.82
63 Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1987 0.81
64 Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects. J Clin Endocrinol Metab 1978 0.81
65 A radioimmunoassay for 3,3',5'-L-triiodothyronine (reverse T3): assessment of thyroid gland content and serum measurements in conditions of normal and altered thyroidal economy and following administration of thyrotropin releasing hormone (TRH) and thyrotropin (TSH). J Clin Endocrinol Metab 1977 0.81
66 Beta receptors in peripheral mononuclear cells increase acutely during exercise. Acta Endocrinol (Copenh) 1985 0.80
67 Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis. Biochem Biophys Res Commun 1991 0.80
68 Trading one "dangerous dogma" for another? Thyroid hormone treatment of the "euthyroid sick syndrome". J Clin Endocrinol Metab 1999 0.80
69 Thyroid hormone homeostasis in states of relative caloric deprivation. Metabolism 1980 0.80
70 Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993 0.80
71 Killer cell activity and antibody-dependent cell-mediated cytotoxicity are normal in Hashimoto's disease. J Clin Endocrinol Metab 1986 0.79
72 The equivalency of two L-thyroxine preparations. Ann Intern Med 1985 0.79
73 Effects of epidermal growth factor on thyroglobulin and adenosine 3',5'-monophosphate production by cultured human thyrocytes. J Clin Endocrinol Metab 1989 0.79
74 Alterations in thyroid iodine release and the peripheral metabolism of thyroxine during acute falciparum malaria in man. J Clin Invest 1972 0.79
75 Malabsorption of thyroxine, calcium, and vitamin D in a thyroparathyroidectomized woman: efficacy of therapy with medium-chain triglyceride oil. Mil Med 1990 0.79
76 Effects of thyroid hormone on the insulin receptor in rat liver membranes. Endocrinology 1982 0.78
77 Atrial natriuretic peptide receptors in human endometrial stromal cells. J Clin Endocrinol Metab 1992 0.78
78 Endothelin binding to receptors and endothelin production by human thyroid follicular cells: effects of transforming growth factor-beta and thyrotropin. J Clin Endocrinol Metab 1993 0.78
79 3'-L-Monoiodothyronine: development of a radioimmunoassay and demonstration of in vivo conversion from 3',5'-diiodothyronine. J Clin Endocrinol Metab 1979 0.78
80 Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 1988 0.78
81 Thyrotropin-releasing hormone tests in an outpatient clinic. South Med J 1985 0.78
82 A clinical guide to the management of Graves' disease with radioactive iodine. Endocr Pract 2004 0.78
83 Ionized and total serum calcium and parathyroid hormone in hyperthyroidism. Ann Intern Med 1976 0.78
84 A radioimmunoassay for 3',5'-diiodothyronine. J Clin Endocrinol Metab 1978 0.78
85 Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. J Clin Endocrinol Metab 1976 0.77
86 Studies of prolactin and TSH secretion by continuous infusion of small amounts of thyrotropin-releasing hormone (TRH). J Clin Endocrinol Metab 1974 0.77
87 Heterogeneity of circulating growth hormone in acromegaly. J Clin Endocrinol Metab 1974 0.77
88 Effect of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine administration on serum tri-, di-, and monoiodothyronines and plasma cyclic nucleotides in sheep. Endocrinology 1980 0.77
89 Radioimmunoassay for 3,5-diiodothyronine and evidence for dependence on conversion from 3,5,3'-triiodothyronine. J Clin Endocrinol Metab 1980 0.77
90 Estimation of the rate of release of non-thyroxine iodine from the thyroid glands of normal subjects and patients with thyrotoxicosis. J Clin Endocrinol Metab 1971 0.77
91 Ipodate restores the fasting-induced decrement in thyrotropin secretion. J Clin Endocrinol Metab 1983 0.77
92 Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: an explanation for decreased thyroid function in systemic illness? Thyroid 1991 0.77
93 Dietary prevention of cataracts in the pink-eyed RCS rat. Lab Anim Sci 1985 0.77
94 Ipodate and 8-anilino-1-naphthalene sulfonic acid block receptor binding of T3 in rat liver. Horm Metab Res 1980 0.76
95 3',5'-diiodothyronine to 3'-monoiodothyronine conversion in the fed and fasted rat: enzyme characteristics and evidence for two distinct 5'-deiodinases. Endocrinology 1981 0.76
96 The effect of experimental hyperthyroidism and hypothyroidism on 5'-monodeiodination of 3,3',5'-triiodothyronine and 3',5'-diiodothyronine by rat liver and kidney. Endocrinology 1982 0.76
97 Antithyroid drugs and radioiodine therapy. Ann Intern Med 1995 0.75
98 L-thyroxine dosage: a reevaluation of therapy with contemporary preparations. Ann Intern Med 1986 0.75
99 Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Andrology 2013 0.75
100 Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Eur J Endocrinol 2013 0.75
101 Lithium and iodine combination therapy for thyrotoxicosis. Acta Endocrinol (Copenh) 1980 0.75
102 Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Horm Res Paediatr 2013 0.75
103 Receptors for endothelin in cultured human thyroid cells and inhibition by endothelin of thyroglobulin secretion. J Clin Endocrinol Metab 1992 0.75
104 Iodine treatment of iodine-induced thyrotoxicosis. J Endocrinol Invest 1981 0.75
105 Neonatal thyrotoxicosis: alterations in serum concentrations of LATS-protector, T4, T3, reverse T3, and 3,3'T2. J Pediatr 1978 0.75
106 A rapid, sensitive enzyme-linked immunoassay for human thyrotropin. Clin Chem 1985 0.75
107 Alterations in T3 and T4 receptor binding in fasting and diabetes mellitus. Life Sci 1981 0.75
108 Deiodination of 131-I-labeled thyroxine in the fetal rat. Proc Soc Exp Biol Med 1973 0.75
109 Conjugated estrogen therapy and tests of thyroid function. Ann Intern Med 1974 0.75
110 Binding of thyrotropin to selected Mycoplasma species: detection of serum antibodies against a specific Mycoplasma membrane antigen in patients with autoimmune thyroid disease. J Endocrinol Invest 1989 0.75
111 Low serum thyroxine and high serum triiodothyronine in nephrotic rats: etiology and implications for bioavailability of protein-bound hormone. Endocrinology 1984 0.75
112 Analysis of human TSH receptor gene and RNA transcripts in patients with thyroid disorders. Autoimmunity 1992 0.75
113 Hyperfunctioning thyroid nodules that become "cold". Med Ann Dist Columbia 1973 0.75
114 c-myc expression in the thyroid. I: Normal, adenomatous, and cancerous thyroid tissue. Horm Metab Res Suppl 1987 0.75
115 Clinical observations on the solitary autonomous thyroid nodule. Arch Intern Med 1974 0.75
116 A rational approach to the treatment of hyperthyroidism. Compr Ther 1988 0.75
117 Effect of an oral water load on serum TSH in normal subjects, and on TSH and prolactin response to thyrotropin-releasing hormone (TRH) in patients with primary hypothyroidism. J Clin Endocrinol Metab 1975 0.75
118 Receptors for atrial natriuretic peptide (ANP) and regulation of thyroglobulin secretion by ANP in human thyroid cells. Life Sci 1989 0.75
119 Anaplastic giant and spindle-cell carcinoma of the thyroid: a different therapeutic approach. Cancer 1980 0.75
120 Pituitary and thyroid function in male cynomolgus monkeys. Lab Anim Sci 1981 0.75
121 Thyrotropin secretion in starved rats is enhanced by somatostatin antiserum. Horm Metab Res 1984 0.75
122 Hyperthyroidism due to a thyrotropin-secreting pituitary adenoma. Studies of thyrotropin and subunit secretion. Arch Intern Med 1982 0.75
123 Intrinsic abnormality of thyroid cells from a patient with a Brobdingnagian goiter. J Endocrinol Invest 1987 0.75
124 Hyperthyroidism. Curr Ther Endocrinol Metab 1994 0.75
125 Guidelines for the treatment of hyperthyroidism. Am Fam Physician 1984 0.75
126 Uremia decreases nuclear 3,5,3'-triiodothyronine receptors in rats. Endocrinology 1980 0.75
127 Iodothyronine levels in human cerebrospinal fluid. J Clin Endocrinol Metab 1982 0.75
128 Effects of drugs on peripheral thyroxine metabolism. Horm Metab Res Suppl 1984 0.75
129 Solitary autonomous thyroid nodules: comparison of fluorescent and pertechnetate imaging. J Nucl Med 1977 0.75
130 Distinguished Service Award. Thyroid 1995 0.75
131 Thyroid carcinoma and Hodgkin's disease. Ann Intern Med 1981 0.75
132 Thyroid function in the intensive care unit setting. Crit Care Clin 2001 0.75
133 c-myc expression in the thyroid. II: Thyrocytes and peripheral and intrathyroidal lymphocytes from patients with autoimmune thyroid disease. Horm Metab Res Suppl 1987 0.75
134 Failure of 3,3'-diiodothyronine administration to alter TSH and prolactin responses to TRH stimulation. Metabolism 1978 0.75
135 Thyrotropin modulates receptors for atrial natriuretic peptide on intact human thyroid cells. Am J Med Sci 1989 0.75
136 Propranolol decreases serum thyroxine as well as triiodothyronine in rats: a protein-binding effect. Endocrinology 1983 0.75
137 Non-thyroxine iodine release from the thyroid during acute malaria. J Clin Endocrinol Metab 1972 0.75
138 Glucagon kinetics in fasting: physiological elevations in serum 3,5,3'-triiodothyronine increase the metabolic clearance rate of glucagon. J Clin Endocrinol Metab 1980 0.75
139 Natural killer cell activity and serum autoantibodies in women with postpartum thyroiditis. J Clin Endocrinol Metab 1988 0.75
140 Thyrotropin modulation of epidermal growth factor (EGF) binding to receptors on cultured thyroid cells. Thyroid 1992 0.75
141 TSH beta subunit gene expression in human lymphocytes. Am J Med Sci 1993 0.75
142 Metabolic clearance and production rates of 3',5'-diiodothyronine in hyperthyroidism and hypothyroidism in man: comparison of infusions using radiolabeled versus unlabeled iodothyronine. J Clin Endocrinol Metab 1981 0.75
143 Iodide administration enhances thyrotrophin responsiveness to thyrotrophin-releasing hormone during fasting: evidence for normal pituitary feedback regulation. Clin Endocrinol (Oxf) 1987 0.75
144 Klinefelter's syndrome: examination of thyroid function, and the TSH and PRL responses to thyrotropin-releasing hormone prior to and after testosterone administration. J Clin Endocrinol Metab 1975 0.75
145 Thyroid iodine content and serum thyroglobulin: cues to the natural history of destruction-induced thyroiditis. J Clin Endocrinol Metab 1986 0.75
146 The effect of dexamethasone, diet control and hyperglycemia on murine hepatic T3 receptors. Life Sci 1981 0.75
147 Eponyms. Ann Intern Med 1988 0.75
148 Quantitative thyroid fluorescent scanning: technique and clinical experience. AJR Am J Roentgenol 1978 0.75
149 Thyrocyte specific killer cell activity is decreased in patients with thyroid carcinoma. Cancer 1987 0.75
150 Expression polymerase chain reaction for the in vitro synthesis and epitope mapping of autoantigen. Application to the human thyrotropin receptor. J Immunol Methods 1993 0.75
151 Physiological or adaptive alterations in the deiodination of thyroxine. Horm Metab Res Suppl 1984 0.75
152 Hypothyroidism after x irradiation to the neck: three case reports and a brief review of the literature. Johns Hopkins Med J 1976 0.75
153 Parameters of thyroid function in patients with active acromegaly. Metabolism 1978 0.75
154 Discordant imaging of a thyroid nodule with 131I and 99mTc: concordance of 131I and fluorescent scans. Radiology 1978 0.75
155 Thyrotropin modulates receptor-mediated processing of the atrial natriuretic peptide receptor in cultured thyroid cells. J Clin Endocrinol Metab 1991 0.75
156 The response of the thyroid gland and thyroid hormone metabolism to infectious disease. Horm Res 1974 0.75